Top

Current Pain and Headache Reports

Published in:

01-02-2018 | Childhood and Adolescent Headache (S Evers, Section Editor)

Pediatric Intracranial Hypertension: a Current Literature Review

Authors: Shawn C. Aylward, Amanda L. Way

Published in: Current Pain and Headache Reports | Issue 2/2018

Abstract

Purpose of Review

The purpose of this review is to provide an update on pediatric intracranial hypertension.

Recent Findings

The annual pediatric incidence is estimated at 0.63 per 100,000 in the USA and 0.71 per 100,000 in Britain. The Idiopathic Intracranial Hypertension Treatment Trial found improvement in visual fields, optical coherence tomography, Frisen grade, and quality of life with acetazolamide compared to placebo in adult patients, and these findings have been translated to the pediatric population.

Summary

Pediatric intracranial hypertension is a disorder that if left untreated can lead to poor quality of life and morbidity. There are no current treatment studies in pediatrics, but adult data suggests acetazolamide remains an acceptable first-line medication.

Quincke H. Uber Meningitis serosa and verwandte Zustande. Dtsch Z Nervenheilkd. 1897;9:149–68. (Atricle in German).CrossRef

Nonne M. Ueber Falle vom Symptomkomplex “tumor cerebri” mit Ausgang in Heilung. Dtsch Z Nervenheilkd. 1904;27(3–4):169–216. https://doi.org/10.1007/BF01667111.CrossRef

Corbett JJ, Savino PJ, Thompson HS, Kansu T, Schatz NJ, Orr LS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39(8):461–74. https://doi.org/10.1001/archneur.1982.00510200003001.CrossRefPubMed

Wall M, Hart WM Jr, Burde RM. Visual field defects in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 1983;96(5):654–69. https://doi.org/10.1016/S0002-9394(14)73425-7.CrossRefPubMed

Foley J. Benign forms of intracranial hypertension; toxic and otitic hydrocephalus. Brain. 1955;78(1):1–41. https://doi.org/10.1093/brain/78.1.1.CrossRefPubMed

Friedman DI. The pseudotumor cerebri syndrome. Neurol Clin. 2014;32(2):363–96. https://doi.org/10.1016/j.ncl.2014.01.001.CrossRefPubMed

• Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159–65. Most recent adult and pediatric revision attempt. https://doi.org/10.1212/WNL.0b013e3182a55f17.CrossRefPubMed

• Aylward SC. Pediatric idiopathic intracranial hypertension: a need for clarification. Pediatr Neurol. 2013;49(5):303–4. Pediatric intracranial hypertension criteria. https://doi.org/10.1016/j.pediatrneurol.2013.05.019.CrossRefPubMed

Sodhi M, Sheldon CA, Carleton B, Etminan M. Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: nested case-control study. Neurology. 2017;89(8):792–5. https://doi.org/10.1212/WNL.0000000000004247.CrossRefPubMed

10.

Dandy WE. Intracranial pressure without brain tumor: diagnosis and treatment. Ann Surg. 1937;106(4):492–513. https://doi.org/10.1097/00000658-193710000-00002.CrossRefPubMedPubMedCentral

11.

Smith JL. Whence pseudotumor cerebri? J Clin Neuroophthalmol. 1985;5(1):55–6.PubMed

12.

Maralani PJ, Hassanlou M, Torres C, Chakraborty S, Kingstone M, Patel V, et al. Accuracy of brain imaging in the diagnosis of idiopathic intracranial hypertension. Clin Radiol. 2012;67(7):656–63. https://doi.org/10.1016/j.crad.2011.12.002.CrossRefPubMed

13.

Gorkem SB, Doganay S, Canpolat M, Koc G, Dogan MS, Per H, et al. MR imaging findings in children with pseudotumor cerebri and comparison with healthy controls. Child’s Nerv Syst. 2015;31(3):373–80. https://doi.org/10.1007/s00381-014-2579-0.CrossRef

14.

• Inger HE, Rogers DL, McGregor ML, Aylward SC, Reem RE. Diagnostic criteria in pediatric intracranial hypertension. J AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus / American Association for Pediatric Ophthalmology and Strabismus. 2017;21(6):492-5 e2. https://doi.org/10.1016/j.jaapos.2017.08.003 Application of past patients with modern proposed criteria.

15.

• Gerstl L, Schoppe N, Albers L, Ertl-Wagner B, Alperin N, Ehrt O, et al. Pediatric idiopathic intracranial hypertension—is the fixed threshold value of elevated LP opening pressure set too high? Eur J Paediatr Neurol. 2017;21(6):833–41. Application of past patients with modern proposed criteria. https://doi.org/10.1016/j.ejpn.2017.08.002.CrossRefPubMed

16.

Tschudy MM, Arcara KM, Johns Hopkins Hospital. Children’s Medical and Surgical Center. The Harriet Lane handbook: a manual for pediatric house officers. 19th ed. Philadelphia: Mosby Elsevier; 2012. xvi, 1132 p., 10 p. of plates p

17.

Swaiman KF. Swaiman’s pediatric neurology: principles and practice. 5th ed. Elsevier Saunders: Edinburgh; 2012.

18.

Rangwala LM, Liu GT. Pediatric idiopathic intracranial hypertension. Surv Ophthalmol. 2007;52(6):597–617. https://doi.org/10.1016/j.survophthal.2007.08.018.CrossRefPubMed

19.

Avery RA, Shah SS, Licht DJ, Seiden JA, Huh JW, Boswinkel J, et al. Reference range for cerebrospinal fluid opening pressure in children. N Engl J Med. 2010;363(9):891–3. https://doi.org/10.1056/NEJMc1004957.CrossRefPubMedPubMedCentral

20.

Lee MW, Vedanarayanan VV. Cerebrospinal fluid opening pressure in children: experience in a controlled setting. Pediatr Neurol. 2011;45(4):238–40. https://doi.org/10.1016/j.pediatrneurol.2011.07.002.CrossRefPubMed

21.

Williams BJ, Skinner HJ, Maria BL. Increased intracranial pressure in a case of pediatric multiple sclerosis. J Child Neurol. 2008;23(6):699–702. https://doi.org/10.1177/0883073807313040.CrossRefPubMed

22.

Narula S, Liu GT, Avery RA, Banwell B, Waldman AT. Elevated cerebrospinal fluid opening pressure in a pediatric demyelinating disease cohort. Pediatr Neurol. 2015;52(4):446–9. https://doi.org/10.1016/j.pediatrneurol.2015.01.002.CrossRefPubMedPubMedCentral

23.

Morgan-Followell B, Aylward SC. Comparison of cerebrospinal fluid opening pressure in children with demyelinating disease to children with primary intracranial hypertension. J Child Neurol. 2017;32(4):366–70. https://doi.org/10.1177/0883073816681936.CrossRefPubMed

24.

7.1.1 Headache attributed to idiopathic intracranial hypertension (IIH). https://www.ichd-3.org/7-headache-attributed-to-non-vascular-intracranial-disorder/7-1-headache-attributed-to-increased-cerebrospinal-fluid-pressure/7-1-1-headache-attributed-to-idiopathic-intracranial-hypertension-iih/.

25.

Avery RA, Mistry RD, Shah SS, Boswinkel J, Huh JW, Ruppe MD, et al. Patient position during lumbar puncture has no meaningful effect on cerebrospinal fluid opening pressure in children. J Child Neurol. 2010;25(5):616–9. https://doi.org/10.1177/0883073809359198.CrossRefPubMedPubMedCentral

26.

Lim MJ, Lin JP. The effects of carbon dioxide on measuring cerebral spinal fluid pressure. Child's Nerv Syst. 2009;25(7):783–4. https://doi.org/10.1007/s00381-009-0902-y.CrossRef

27.

•• Durcan FJ, Corbett JJ, Wall M. The incidence of pseudotumor cerebri. Population studies in Iowa and Louisiana. Arch Neurol. 1988;45(8):875–7. First report of pediatric incidence in the United States. https://doi.org/10.1001/archneur.1988.00520320065016.CrossRefPubMed

28.

Gillson N, Jones C, Reem RE, Rogers DL, Zumberge N, Aylward SC. Incidence and demographics of pediatric intracranial hypertension. Pediatr Neurol. 2017;73:42–7. https://doi.org/10.1016/j.pediatrneurol.2017.04.021.CrossRefPubMed

29.

Tibussek D, Distelmaier F, von Kries R, Mayatepek E. Pseudotumor cerebri in childhood and adolescence—results of a Germany-wide ESPED-survey. Klin Padiatr. 2013;225(2):81–5. https://doi.org/10.1055/s-0033-1333757.CrossRefPubMed

30.

Dessardo NS, Dessardo S, Sasso A, Sarunic AV, Dezulovic MS. Pediatric idiopathic intracranial hypertension: clinical and demographic features. Coll Antropol. 2010;34(Suppl 2):217–21.PubMed

31.

Matthews YY, Dean F, Lim MJ, McLachlan K, Rigby AS, Solanki GA, et al. Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study. Arch Dis Child. 2017;102(8):715–21. https://doi.org/10.1136/archdischild-2016-312238.CrossRefPubMed

32.

Tibussek D, Schneider DT, Vandemeulebroecke N, Turowski B, Messing-Juenger M, Willems PH, et al. Clinical spectrum of the pseudotumor cerebri complex in children. Child’s Nerv Syst. 2010;26(3):313–21. https://doi.org/10.1007/s00381-009-1018-0.CrossRef

33.

Bursztyn LL, Sharan S, Walsh L, LaRoche GR, Robitaille J, De Becker I. Has rising pediatric obesity increased the incidence of idiopathic intracranial hypertension in children? Can J Ophthalmol. 2014;49(1):87–91. https://doi.org/10.1016/j.jcjo.2013.09.015.CrossRefPubMed

34.

Beri S, Chandratre S, Chow G. Familial idiopathic intracranial hypertension with variable phenotype. Eur J Paediatr Neurol. 2011;15(1):81–3. https://doi.org/10.1016/j.ejpn.2010.02.005.CrossRefPubMed

35.

Corbett JJ. The first Jacobson Lecture. Familial idiopathic intracranial hypertension. J Neuroophthalmol. 2008;28(4):337–47. https://doi.org/10.1097/WNO.0b013e31818f12a2.CrossRefPubMed

36.

Polemikos M, Heissler HE, Hermann EJ, Krauss JK. Idiopathic intracranial hypertension in monozygotic female twins: intracranial pressure dynamics and treatment outcome. World Neurosurg. 2017;101:814 e11–4. https://doi.org/10.1016/j.wneu.2017.03.004.CrossRef

37.

•• Aylward SC, Aronowitz C, Roach ES. Intracranial hypertension without papilledema in children. J Child Neurol. 2016;31(2):177–83. IIHTT outcomes in the first large-scale adult trial. https://doi.org/10.1177/0883073815587029.CrossRefPubMed

38.

Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache. 2017;57(8):1303–10. https://doi.org/10.1111/head.13144.CrossRefPubMed

39.

Aylward SC, Aronowitz C, Reem R, Rogers D, Roach ES. Intracranial hypertension without headache in children. J Child Neurol. 2015;30(6):703–6. https://doi.org/10.1177/0883073814540522.CrossRefPubMed

40.

Aylward SC, Waslo CS, Au JN, Tanne E. Manifestations of pediatric intracranial hypertension from the intracranial hypertension registry. Pediatr Neurol. 2016;61:76–82. https://doi.org/10.1016/j.pediatrneurol.2016.04.007.CrossRefPubMed

41.

Brainard L, Chen DA, Aziz KM, Hillman TA. Association of benign intracranial hypertension and spontaneous encephalocele with cerebrospinal fluid leak. Otol Neurotol. 2012;33(9):1621–4. https://doi.org/10.1097/MAO.0b013e318271c312.CrossRefPubMed

42.

Rosenfeld E, Dotan G, Kimchi TJ, Kesler A. Spontaneous cerebrospinal fluid otorrhea and rhinorrhea in idiopathic intracranial hypertension patients. J Neuroophthalmol. 2013;33(2):113–6. https://doi.org/10.1097/WNO.0b013e18274b870.CrossRefPubMed

43.

Kunte H, Schmidt F, Kronenberg G, Hoffmann J, Schmidt C, Harms L, et al. Olfactory dysfunction in patients with idiopathic intracranial hypertension. Neurology. 2013;81(4):379–82. https://doi.org/10.1212/WNL.0b013e31829c5c9d.CrossRefPubMed

44.

Bershad EM, Urfy MZ, Calvillo E, Tang R, Cajavilca C, Lee AG, et al. Marked olfactory impairment in idiopathic intracranial hypertension. J Neurol Neurosurg Psychiatry. 2014;85(9):959–64. https://doi.org/10.1136/jnnp-2013-307232.CrossRefPubMed

45.

Kharkar S, Hernandez R, Batra S, Metellus P, Hillis A, Williams MA, et al. Cognitive impairment in patients with pseudotumor cerebri syndrome. Behav Neurol. 2011;24(2):143–8. https://doi.org/10.1155/2011/630475.CrossRefPubMedPubMedCentral

46.

Yri HM, Fagerlund B, Forchhammer HB, Jensen RH. Cognitive function in idiopathic intracranial hypertension: a prospective case-control study. BMJ Open. 2014;4(4):e004376. https://doi.org/10.1136/bmjopen-2013-004376.CrossRefPubMedPubMedCentral

47.

•• Zur D, Naftaliev E, Kesler A. Evidence of multidomain mild cognitive impairment in idiopathic intracranial hypertension. J Neuroophthalmol. 2015;35(1):26–30. Papilledema grading scale. https://doi.org/10.1097/WNO.0000000000000199.CrossRefPubMed

48.

•• Frisen L. Swelling of the optic nerve head: a staging scheme. J Neurol Neurosurg Psychiatry. 1982;45(1):13–8. Comparison of pediatric imaging in papilledema vs pseudopapilledema. https://doi.org/10.1136/jnnp.45.1.13.CrossRefPubMedPubMedCentral

49.

Chang MY, Velez FG, Demer JL, Bonelli L, Quiros PA, Arnold AC, et al. Accuracy of diagnostic imaging modalities for classifying pediatric eyes as papilledema versus pseudopapilledema. Ophthalmology. 2017;124(12):1839–48. https://doi.org/10.1016/j.ophtha.2017.06.016.CrossRefPubMed

50.

Atta HR. Imaging of the optic nerve with standardised echography. Eye (Lond). 1988;2(Pt 4):358–66. https://doi.org/10.1038/eye.1988.66.CrossRefPubMed

51.

Irazuzta JE, Brown ME, Akhtar J. Bedside optic nerve sheath diameter assessment in the identification of increased intracranial pressure in suspected idiopathic intracranial hypertension. Pediatr Neurol. 2016;54:35–8. https://doi.org/10.1016/j.pediatrneurol.2015.08.009.CrossRefPubMed

52.

Carter SB, Pistilli M, Livingston KG, Gold DR, Volpe NJ, Shindler KS, et al. The role of orbital ultrasonography in distinguishing papilledema from pseudopapilledema. Eye (Lond). 2014;28(12):1425–30. https://doi.org/10.1038/eye.2014.210.CrossRef

53.

Kurz-Levin MM, Landau KA. Comparison of imaging techniques for diagnosing drusen of the optic nerve head. Arch Ophthalmol. 1999;117(8):1045–9. https://doi.org/10.1001/archopht.117.8.1045.CrossRefPubMed

54.

Kulkarni KM, Pasol J, Rosa PR, Lam BL. Differentiating mild papilledema and buried optic nerve head drusen using spectral domain optical coherence tomography. Ophthalmology. 2014;121(4):959–63. https://doi.org/10.1016/j.ophtha.2013.10.036.CrossRefPubMed

55.

El-Dairi MA, Holgado S, O'Donnell T, Buckley EG, Asrani S, Freedman SF. Optical coherence tomography as a tool for monitoring pediatric pseudotumor cerebri. J AAPOS. 2007;11(6):564–70. https://doi.org/10.1016/j.jaapos.2007.06.018.CrossRefPubMed

56.

Martinez MR, Ophir A. Optical coherence tomography as an adjunctive tool for diagnosing papilledema in young patients. J Pediatr Ophthalmol Strabismus. 2011;48(3):174–81. https://doi.org/10.3928/01913913-20100719-05.CrossRefPubMed

57.

Lee YA, Tomsak RL, Sadikovic Z, Bahl R, Sivaswamy L. Use of ocular coherence tomography in children with idiopathic intracranial hypertension—a single-center experience. Pediatr Neurol. 2016;58:101–6 e1. https://doi.org/10.1016/j.pediatrneurol.2015.10.022.CrossRefPubMed

58.

Pineles SL, Arnold AC. Fluorescein angiographic identification of optic disc drusen with and without optic disc edema. J Neuroophthalmol. 2012;32(1):17–22. https://doi.org/10.1097/WNO.0b013e31823010b8.CrossRefPubMedPubMedCentral

59.

Fraser JA, Leung AE. Reversibility of MRI features of pseudotumor cerebri syndrome. J Can Sci Neurol. 2014;41(4):530–2. https://doi.org/10.1017/S0317167100018643.CrossRef

60.

Hartmann AJ, Soares BP, Bruce BB, Saindane AM, Newman NJ, Biousse V, et al. Imaging features of idiopathic intracranial hypertension in children. J Child Neurol. 2017;32(1):120–6. https://doi.org/10.1177/0883073816671855.CrossRefPubMed

61.

Horev A, Hallevy H, Plakht Y, Shorer Z, Wirguin I, Shelef I. Changes in cerebral venous sinuses diameter after lumbar puncture in idiopathic intracranial hypertension: a prospective MRI study. J Neuroimaging. 2013;23(3):375–8. https://doi.org/10.1111/j.1552-6569.2012.00732.x.CrossRefPubMed

62.

Johnston I, Paterson A. Benign intracranial hypertension. II. CSF pressure and circulation. Brain. 1974;97(2):301–12.

63.

McLaren SH, Monuteaux MC, Delaney AC, Landschaft A, Kimia AA. How much cerebrospinal fluid should we remove prior to measuring a closing pressure? J Child Neurol. 2017;32(4):356–9. https://doi.org/10.1177/0883073816681352.CrossRefPubMed

64.

Hatfield MK, Handrich SJ, Willis JA, Beres RA, Zaleski GX. Blood patch rates after lumbar puncture with Whitacre versus Quincke 22- and 20-gauge spinal needles. AJR Am J Roentgenol. 2008;190(6):1686–9. https://doi.org/10.2214/AJR.07.3351.CrossRefPubMed

65.

Engedal TS, Ording H, Vilholm OJ. Changing the needle for lumbar punctures: results from a prospective study. Clin Neurol Neurosurg. 2015;130:74–9. https://doi.org/10.1016/j.clineuro.2014.12.020.CrossRefPubMed

66.

Castrillo A, Tabernero C, Garcia-Olmos LM, Gil C, Gutierrez R, Zamora MI, et al. Postdural puncture headache: impact of needle type, a randomized trial. Spine J. 2015;15(7):1571–6. https://doi.org/10.1016/j.spinee.2015.03.009.CrossRefPubMed

67.

Bellamkonda VR, Wright TC, Lohse CM, Keaveny VR, Funk EC, Olson MD, et al. Effect of spinal needle characteristics on measurement of spinal canal opening pressure. Am J Emerg Med. 2017;35(5):769–72. https://doi.org/10.1016/j.ajem.2017.01.047.CrossRefPubMed

68.

Berezovsky DE, Bruce BB, Vasseneix C, Peragallo JH, Newman NJ, Biousse V. Cerebrospinal fluid total protein in idiopathic intracranial hypertension. J Neurol Sci. 2017;381:226–9. https://doi.org/10.1016/j.jns.2017.08.3264.CrossRefPubMed

69.

Celebisoy N, Gokcay F, Sirin H, Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116(5):322–7. https://doi.org/10.1111/j.1600-0404.2007.00905.x.CrossRefPubMed

70.

Ko MW, Chang SC, Ridha MA, Ney JJ, Ali TF, Friedman DI, et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology. 2011;76(18):1564–7. https://doi.org/10.1212/WNL.0b013e3182190f51.CrossRefPubMed

71.

Sinclair AJ, Burdon MA, Nightingale PG, Ball AK, Good P, Matthews TD, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341(jul07 2):c2701. https://doi.org/10.1136/bmj.c2701.CrossRefPubMedPubMedCentral

72.

Johnson LN, Krohel GB, Madsen RW, March GA Jr. The role of weight loss and acetazolamide in the treatment of idiopathic intracranial hypertension (pseudotumor cerebri). Ophthalmology. 1998;105(12):2313–7. https://doi.org/10.1016/S0161-6420(98)91234-9.CrossRefPubMed

73.

Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology. 2000;107(10):1907–12. https://doi.org/10.1016/S0161-6420(00)00340-7.CrossRefPubMed

74.

Alsuhaibani AH, Carter KD, Nerad JA, Lee AG. Effect of optic nerve sheath fenestration on papilledema of the operated and the contralateral nonoperated eyes in idiopathic intracranial hypertension. Ophthalmology. 2011;118(2):412–4. https://doi.org/10.1016/j.ophtha.2010.06.025.CrossRefPubMed

75.

Plotnik JL, Kosmorsky GS. Operative complications of optic nerve sheath decompression. Ophthalmology. 1993;100(5):683–90. https://doi.org/10.1016/S0161-6420(93)31588-5.CrossRefPubMed

76.

Abubaker K, Ali Z, Raza K, Bolger C, Rawluk D, O'Brien D. Idiopathic intracranial hypertension: lumboperitoneal shunts versus ventriculoperitoneal shunts—case series and literature review. Br J Neurosurg. 2011;25(1):94–9. https://doi.org/10.3109/02688697.2010.544781.CrossRefPubMed

77.

Liu A, Elder BD, Sankey EW, Goodwin CR, Jusue-Torres I, Rigamonti D. Are shunt series and shunt patency studies useful in patients with shunted idiopathic intracranial hypertension in the emergency department? Clin Neurol Neurosurg. 2015;138:89–93. https://doi.org/10.1016/j.clineuro.2015.08.008.CrossRefPubMed

78.

Liu A, Elder BD, Sankey EW, Goodwin CR, Jusue-Torres I, Rigamonti D. The utility of computed tomography in shunted patients with idiopathic intracranial hypertension presenting to the emergency department. World Neurosurg. 2015;84(6):1852–6. https://doi.org/10.1016/j.wneu.2015.08.008.CrossRefPubMed

79.

Ahmed RM, Wilkinson M, Parker GD, Thurtell MJ, Macdonald J, McCluskey PJ, et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. AJNR Am J Neuroradiol. 2011;32(8):1408–14. https://doi.org/10.3174/ajnr.A2575.CrossRefPubMed

80.

Radvany MG, Solomon D, Nijjar S, Subramanian PS, Miller NR, Rigamonti D, et al. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis. J Neuroophthalmol. 2013;33(2):117–22. https://doi.org/10.1097/WNO.0b013e31827f18eb.CrossRefPubMed

81.

Kumpe DA, Bennett JL, Seinfeld J, Pelak VS, Chawla A, Tierney M. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg. 2012;116(3):538–48. https://doi.org/10.3171/2011.10.JNS101410.CrossRefPubMed

82.

Ahmed RM, Zmudzki F, Parker GD, Owler BK, Halmagyi GM. Transverse sinus stenting for pseudotumor cerebri: a cost comparison with CSF shunting. AJNR Am J Neuroradiol. 2014;35(5):952–8. https://doi.org/10.3174/ajnr.A3806.CrossRefPubMed

83.

Digre KB, Bruce BB, McDermott MP, Galetta KM, Balcer LJ, Wall M, et al. Quality of life in idiopathic intracranial hypertension at diagnosis: IIH treatment trial results. Neurology. 2015;84(24):2449–56. https://doi.org/10.1212/WNL.0000000000001687.CrossRefPubMedPubMedCentral

84.

Mulla Y, Markey KA, Woolley RL, Patel S, Mollan SP, Sinclair AJ. Headache determines quality of life in idiopathic intracranial hypertension. J Headache Pain. 2015;16(1):521.CrossRefPubMed

85.

Ravid S, Shahar E, Schif A, Yehudian S. Visual outcome and recurrence rate in children with idiopathic intracranial hypertension. J Child Neurol. 2015;30(11):1448–52. https://doi.org/10.1177/0883073815569306.CrossRefPubMed

86.

Gospe SM 3rd, Bhatti MT, El-Dairi MA. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension. Br J Ophthalmol. 2016;100(4):505–9. https://doi.org/10.1136/bjophthalmol-2015-307043.CrossRefPubMed

87.

Agarwal A, Vibha D, Prasad K, Bhatia R, Singh MB, Garg A, et al. Predictors of poor visual outcome in patients with idiopathic intracranial hypertension (IIH): an ambispective cohort study. Clin Neurol Neurosurg. 2017;159:13–8. https://doi.org/10.1016/j.clineuro.2017.05.009.CrossRefPubMed

Title: Pediatric Intracranial Hypertension: a Current Literature Review
Authors: Shawn C. Aylward
Amanda L. Way
Publication date: 01-02-2018
Publisher: Springer US
Published in: Current Pain and Headache Reports / Issue 2/2018
Print ISSN: 1531-3433
Electronic ISSN: 1534-3081
DOI: https://doi.org/10.1007/s11916-018-0665-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pediatric Intracranial Hypertension: a Current Literature Review

Abstract

Purpose of Review

Recent Findings

Summary

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 2/2018

Migraine and the Hippocampus

Chronification of Pain: Mechanisms, Current Understanding, and Clinical Implications

Complex Regional Pain Syndrome, Current Concepts and Treatment Options

The Effect of Ketamine Infusion in the Treatment of Complex Regional Pain Syndrome: a Systemic Review and Meta-analysis

Intrathecal Drug Delivery and Spinal Cord Stimulation for the Treatment of Cancer Pain